JOHN RIMER: Open Payments
NPI 1508884594 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,445 in 99 payments from 16 companies in 2025. Trend: 2023 $5,701 · 2024 $4,253 · 2025 $3,445
Food & beverage: $2,613Consulting: $760Education: $72
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 6 | $858 |
| ABBVIE INC. | 7 | $347 |
| Amgen Inc. | 9 | $315 |
| Regeneron Healthcare Solutions, Inc. | 11 | $284 |
| Janssen Biotech, Inc. | 17 | $280 |
| GENZYME CORPORATION | 10 | $275 |
| Galderma Laboratories, L.P. | 7 | $258 |
| Novartis Pharmaceuticals Corporation | 4 | $213 |
| PFIZER INC. | 8 | $158 |
| Arcutis Biotherapeutics, Inc. | 6 | $152 |
Products named: Bimzelx, DUPIXENT, SKYRIZI, OTEZLA, TREMFYA, NEMLUVIO, CIBINQO, Zoryve.
Industry payments across AZ — which companies pay providers there.
